These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1429075)

  • 21. Predictive value of codon 215 reverse transcriptase mutation on the efficacy of didanosine in HIV-infected, zidovudine-experienced patients.
    Yerly S; Denereaz N; Mermillod B; Hirschel B; Perrin L
    Antivir Ther; 1996 Aug; 1(3):167-71. PubMed ID: 11322250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.
    Molina JM; Chêuc G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM;
    Antivir Ther; 1999; 4 Suppl 3():71-4. PubMed ID: 16021874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ALBI trial: a randomized controlled trial comparing stavudine plus didanosine with zidovudine plus lamivudine and a regimen alternating both combinations in previously untreated patients infected with human immunodeficiency virus.
    Molina JM; Chêne G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM
    J Infect Dis; 1999 Aug; 180(2):351-8. PubMed ID: 10395849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacotherapy of HIV. APhA Editorial Board on Pharmaceutical Care for Patients with HIV Infection.
    Am Pharm; 1994 Feb; NS34(2):60-9; quiz 69-70. PubMed ID: 8166046
    [No Abstract]   [Full Text] [Related]  

  • 25. [Zidovudine plus didanosine in HIV infected asymptomatic patients previously treated with zidovudine].
    López-Martínez C; Guarner J; Magis-Rodríguez C; Uribe-Zúñiga P; del Río-Chiriboga C
    Rev Invest Clin; 1998; 50(4):335-9. PubMed ID: 9830323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Once-daily administration of didanosine in combination with anti-retroviral zidovudine in previously untreated patients].
    Reynes J; Montes B; Delmas B; Vendrell JP; Janbon F; Segondy M
    Pathol Biol (Paris); 1997 May; 45(5):441-4. PubMed ID: 9296101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combination therapies with anti-retroviral agents in HIV and AIDS infections].
    Fernández-Cruz E
    Rev Clin Esp; 1991 Oct; 189(6):253-5. PubMed ID: 1722345
    [No Abstract]   [Full Text] [Related]  

  • 28. Study of AZT effectiveness in treating HIV-infected children halted.
    J Am Osteopath Assoc; 1995 Mar; 95(3):211. PubMed ID: 7751172
    [No Abstract]   [Full Text] [Related]  

  • 29. [Current developments in antiviral chemotherapy. Part 4: Foscarnet, zidovudine, didanosine].
    Stamminger T; Fleckenstein B
    Fortschr Med; 1994 May; 112(13):190-1. PubMed ID: 8020860
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapeutic advantage of hydroxyurea and didanosine combination therapy in patients previously treated with zidovudine.
    Foli A; Maserati R; Minoli L; Wainberg MA; Gallo RC; Lisziewicz J; Lori F
    AIDS; 1998 Jun; 12(9):1113-4. PubMed ID: 9662215
    [No Abstract]   [Full Text] [Related]  

  • 31. New developments in dideoxynucleoside antiretroviral therapy for HIV infection.
    Fischl MA
    AIDS Clin Rev; 1991; ():197-214. PubMed ID: 1651100
    [No Abstract]   [Full Text] [Related]  

  • 32. Protection of human immunodeficiency virus encephalitis by a switch from zidovudine to didanosine.
    Chrétien F; Gray F; de Truchis P; Bélec L; Levy Y; Dubreuil-Lemaire ML
    Antimicrob Agents Chemother; 1996 Jan; 40(1):278. PubMed ID: 8787925
    [No Abstract]   [Full Text] [Related]  

  • 33. Didanosine and ACTG 116A.
    Higgins S; Woolley PD; Chandiok S
    Lancet; 1993 Feb; 341(8844):570. PubMed ID: 8094822
    [No Abstract]   [Full Text] [Related]  

  • 34. Treating HIV infection: what pharmacists need to know.
    Wong RJ
    Am Pharm; 1993 May; NS33(5):57-64. PubMed ID: 8333410
    [No Abstract]   [Full Text] [Related]  

  • 35. [AIDS therapy--new perspectives for the 90s].
    Immun Infekt; 1991 Feb; 19(1):III. PubMed ID: 2060959
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical perspectives in the treatment of HIV disease: the role of didanosine. Chicago, Illinois, 28 September 1991.
    Clin Infect Dis; 1993 Feb; 16 Suppl 1():S1-73. PubMed ID: 8425016
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical perspectives in the treatment of HIV disease: the role of didanosine. Introduction.
    Corey L
    Clin Infect Dis; 1993 Feb; 16 Suppl 1():S1. PubMed ID: 8425015
    [No Abstract]   [Full Text] [Related]  

  • 38. BDEWF New Writers' Workshop.
    Br Dent J; 2020 Jul; 229(2):85. PubMed ID: 32710049
    [No Abstract]   [Full Text] [Related]  

  • 39. New Writers' Workshop returns.
    Br Dent J; 2021 Sep; 231(6):321. PubMed ID: 34561571
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.